cilostazol has been researched along with Liver Diseases in 2 studies
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacokinetic profiles of cilostazol and its metabolites following a single oral dose of cilostazol 100 mg were compared between individuals with impaired and normal liver function." | 2.69 | Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazol. ( Bramer, SL; Forbes, WP, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nomura, K | 1 |
| Miyashita, T | 1 |
| Yamamoto, Y | 1 |
| Munesue, S | 1 |
| Harashima, A | 1 |
| Takayama, H | 1 |
| Fushida, S | 1 |
| Ohta, T | 1 |
| Bramer, SL | 1 |
| Forbes, WP | 1 |
1 trial available for cilostazol and Liver Diseases
| Article | Year |
|---|---|
Effect of hepatic impairment on the pharmacokinetics of a single dose of cilostazol.
Topics: Administration, Oral; Adult; Area Under Curve; Cilostazol; Half-Life; Humans; Liver Diseases; Male; | 1999 |
1 other study available for cilostazol and Liver Diseases
| Article | Year |
|---|---|
Citrullinated Histone H3: Early Biomarker of Neutrophil Extracellular Traps in Septic Liver Damage.
Topics: Animals; Biomarkers; Cilostazol; Citrullination; Extracellular Traps; Histones; Lipopolysaccharides; | 2019 |